Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
PAZOPANIB TABLETS. These highlights do not include all the information needed to use PAZOPANIB TABLETS safely and effectively. See full prescribing information for PAZOPANIB TABLETS. PAZOPANIB tablets, for oral use Initial U.S. Approval: 2009
Medication labelWhy this: Advisory · dailymed-prescription
Pazopanib tablets are indicated for the treatment of adults with advanced renal cell carcinoma (RCC). Pazopanib tablets are indicated for the treatment of adults with advanced soft tissue sarcoma (STS) who have received prior chemotherapy. Limitations of Use: The efficacy of pazopanib tablets for the treatment of patients with adipocytic STS or gastrointestinal stromal tumors has not been demonstrated.
- generic_name
- pazopanib
- product_names
- Pazopanib
- ndc
- 51407-872, 60505-4779, 51407-872-12
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en